Christopher Barbieri
Cornell University
H-index: 42
North America-United States
Top articles of Christopher Barbieri
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
TREM2 is a radiation-induced target for immunomodulation of tumor-associated macrophages in the prostate cancer tumor microenvironment | Cancer Research | Janny A Villa-Pulgarin Un In Chan Francesca Khani Fabio Socciarelli Jiansheng Wu | 2024/3/22 |
Canonical AREs are tumor suppressive regulatory elements in the prostate | bioRxiv | Michael A Augello Xuanrong Chen Deli Liu Kevin Lin Alex Hakansson | 2024 |
RADIATION THERAPY AND IRREVERSIBLE ELECTROPORATION (RTIRE) FOR INTERMEDIATE RISK PROSTATE CANCER: A PHASE II ONGOING TRIAL | Timothy D McClure Karla V Ballman Ariel EE Marciscano Christopher Barbieri Himanshu Nagar | 2023/2/20 | |
ASCERTAINING PROVIDER-LEVEL IMPLICIT BIAS IN THE TREATMENT OF PROSTATE CANCER UTILIZING NATURAL LANGUAGE PROCESSING TECHNIQUES | Urologic Oncology: Seminars and Original Investigations | Ashwin Ramaswamy Michael Hung Joe Pelt Parsa Iranmahboub Lina Posada Calderon | 2024/3/1 |
Rapid quantification of prostate specific antigen (PSA) from fingerstick (FS) blood. | Joseph Earl Thomas Balaji Srinivasan Nicole Jacobs Alfred Winkler Zhen Zhao | 2024/2/1 | |
166 Radiation Therapy and IRreversible Electroporation (RTIRE) for Intermediate Risk Prostate Cancer | Journal of Clinical and Translational Science | Timothy McClure Francesca Khani Brian Robinson Ariel E Marciscano Christopher Barbieri | 2024/4 |
Distinct mesenchymal cell states mediate prostate cancer progression | Nature Communications | Hubert Pakula Mohamed Omar Ryan Carelli Filippo Pederzoli Giuseppe Nicolò Fanelli | 2024/1/8 |
Randomized Trial of Five or Two MRI-guided Adaptive Radiotherapy Treatments for Prostate Cancer (FORT) | Ariel EE Marciscano Xi K Zhou Sydney Wolfe Amar Upadhyaya Kishan Michael L Steinberg | 2023/2/20 | |
PD39-05 IMPACT OF MRI-TARGETING ON PATHOLOGIC UPGRADING AND DOWNGRADING AT PROSTATECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS | Ilon Weinstein Xian Wu Alexander Hill Donald Brennan Danly Omil-Lima | 2023/4 | |
Impact of magnetic resonance imaging targeting on pathologic upgrading and downgrading at prostatectomy: A systematic review and meta-analysis | Ilon C Weinstein Xian Wu Alexander Hill Donald Brennan Danly Omil-Lima | 2023/5/25 | |
Dynamic Changes of Molecular Subtype Classification and Genomic Classifier Scores in High-Risk Prostate Cancer Patients Undergoing Pre-Operative Stereotactic Body Radiation Therapy | International Journal of Radiation Oncology, Biology, Physics | M Diven A Hakansson Y Liu E Davicioni A Dillard | 2023/10/1 |
Effect of neoadjuvant stereotactic body radiation therapy (SBRT) on the immune microenvironment of high-risk localized prostate cancer in paired transcriptomic analysis of … | Ariel EE Marciscano Alicia Dillard Alexander K Hakansson Yang Liu Elai Davicioni | 2023/2/20 | |
SMAD3 promotes expression and activity of the androgen receptor in prostate cancer | Nucleic Acids Research | Hee-Young Jeon Majid Pornour Hyunju Ryu Sudeep Khadka Rui Xu | 2023/4/11 |
Plasma metabolomics profiling of 580 patients from an Early Detection Research Network prostate cancer cohort | Scientific Data | Elisa Benedetti Kelsey Chetnik Thomas Flynn Christopher E Barbieri Douglas S Scherr | 2023/11/25 |
Longitudinal Profiling of Tumor RNA Expression Signatures Reveal Key Biological Features Associated with Response to Neoadjuvant Stereotactic Body Radiation Therapy in High … | International Journal of Radiation Oncology, Biology, Physics | M Diven A Dillard F Khani S Wolfe E Davicioni | 2023/10/1 |
Randomized trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks vs. 2 weeks (SHORTER). | Ariel EE Marciscano Xi K Zhou Christopher Barbieri Jim C Hu Douglas Scherr | 2023/2/20 | |
Mesenchymal cell populations associated with different stages of prostate cancer progression in mice and human | Cancer Research | Mohamed Omar Hubert Pakula Filippo Pederzoli Giuseppe N Fanelli Tania Panellinni | 2023/4/4 |
SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression | Clinical Cancer Research | Chuandong Geng Man-Chao Zhang Ganiraju C Manyam Jody V Vykoukal Johannes F Fahrmann | 2023/11/1 |
Predictive Value of Genomic Classifier Scores and Transcriptomic Data for Prostate Cancer Distant Metastasis Risk: A Multicenter Retrospective Study | International Journal of Radiation Oncology, Biology, Physics | J Nikitas K Subramanian J Proudfoot E Davicioni A Ricaurte-Fajardo | 2023/10/1 |
Comparative transcriptomic analysis of DNA-damage response and androgen receptor pathway activity between biopsy and radical prostatectomy specimens before and after pre … | Himanshu Nagar Alicia Dillard Alexander K Hakansson Yang Liu Elai Davicioni | 2023/2/20 |
Co-Authors
